Harvard Pilgrim Health Care has entered into its third outcomes-based pharmaceutical contract tying what it pays for drugs to how well the patient does on the medicine. In its most recent agreement, ...

Melbourne, Australia-based Adherium, a digital health company that focuses in improving medication adherence and patient outcomes, has just received FDA clearance for a new inhaler monitoring device ...

Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called ...

(Reuters) -AstraZeneca breached the UK pharmaceutical industry's code of practice after a website claim incorrectly stated that all newly diagnosed asthma patients aged 12 and above should receive its ...

Pittsburgh-based Highmark Health signed an outcomes-based contract with drugmaker AstraZeneca for its asthma and chronic obstructive pulmonary disease drug Symbicort. The contract will apply to ...

AstraZeneca announced in its first-quarter presentation (PDF) on Tuesday that it had stopped working on a phase 1 Alzheimer's disease drug and two phase 2 programs for migraine and osteoarthritis pain ...